Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy
Citations Over TimeTop 1% of 2022 papers
Abstract
Near-infrared (NIR) fluorophores have unique features that endow them with several advantages over conventional shorter wavelength emitting dyes. As a result, they have been widely utilized as fluorescence and photoacoustic imaging agents, as well as photodynamic and photothermal therapeutic agents. However, non-targeting NIR fluorescence-emitting organic molecules have the drawback of low selectivity toward tumors, which potentially results in severe side effects caused by damage to normal tissues. Thus, the development of NIR fluorophore-based substances that target tumors is a highly active area in medicinal chemistry research. Research efforts carried out thus far have led to the development of a number of NIR fluorophore-based, tumor imaging and therapeutic agents. The discussion in this review focuses on the results of research reported in the 2012-2021 period, giving particular emphasis to studies of NIR small organic dye-based imaging and therapeutic agents that are designed utilizing cancer-selective strategies.
Related Papers
- → Two-dimensional TiS2 nanosheets for in vivo photoacoustic imaging and photothermal cancer therapy(2015)216 cited
- → Physically-synthesized gold nanoparticles containing multiple nanopores for enhanced photothermal conversion and photoacoustic imaging(2016)30 cited
- → A thermosensitive nanoplatform for photoacoustic imaging and NIR light triggered chemo-photothermal therapy(2020)20 cited
- → Human CIK Cells Loaded with Gold Nanoprisms as Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immuno-Photothermal Combined Therapy(2016)13 cited
- → Photothermal Therapy: Biodegradable Bi2O2Se Quantum Dots for Photoacoustic Imaging‐Guided Cancer Photothermal Therapy (Small 1/2020)(2020)10 cited